Selective reduction of the septolateral dimensions in functional mitral regurgitation by modified-shape ring annuloplasty  by Maisano, Francesco et al.
method has the potential to revolutionize the field of cardiotho-
racic surgery. Most of all, the continued joint efforts of devel-
opmental biologists and material scientists and engineers in the
area of cell printing may lead to faster tissue construction, a
cornerstone to making regenerative medicine a clinical possi-
bility.
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Selective reduction of the septolateral dimensions in functional mitral
regurgitation by modified-shape ring annuloplasty
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Undersized annuloplasty is the conventional surgicaltreatment for functional mitral regurgitation (FMR).1The rationale of this approach is the reduction theannular diameter to force leaflet coaptation. When this
technique is performed with a conventional annuloplasty prosthe-
sis, the transverse and septolateral dimensions are proportionally
reduced. However, it has been suggested that the main determinant
of malcoaptation in FMR is the increase of the septolateral dimen-
sion.2 Therefore, intercommissural distance reduction is probably
unnecessary, if not detrimental (it may induce anterior leaflet
folding and unnecessary reduction of the total mitral valve orifice
area).
We herein present an alternative method for annuloplasty,
designed to selectively reduce the septolateral dimension in FMR,
which is intended to improve the results of mitral repair in this
challenging group of patients.3
Surgical Technique and Clinical Experience
A Carpentier rigid ring (Edwards Lifesciences Inc, Irvine, Calif)
was chosen because it contains a metal core that can be reshaped.
Prosthesis size was selected by measuring the intertrigonal dis-
tance and was undersized by 1 size. Before implantation, the ring
was reshaped according to the sequence illustrated in Figure 1 by
use of 2 tubing clamps. Shape modification created a prosthesis
with the intertrigonal distance upsized by 1 size (and therefore
normalized to the native valve intertrigonal dimension) and the
septolateral distance undersized by 1 size (therefore, the septolat-
eral dimension was doubly undersized), resulting in a nearly 2:1
intercommissural-septolateral ratio (as compared with the standard
4:3 ratio).
We used this approach in 14 patients with FMR between March
and December 2003. There were 12 men and 2 women, with a
mean age of 56  11 years. Ten patients had ischemic and 4 had
idiopathic cardiomyopathy. Preoperative mean functional class
was 2.6  0.6. FMR was severe in 12 patients and moderate in 2
(the mean regurgitation grade was 3.8 0.6). The mean coaptation
depth was 1.09  0.44 cm (range, 0.6-2.0 cm) and exceeded 1 cm
in 6 patients.4 A complex regurgitant jet (eccentric or multiple)
was detected in 9 patients.5 The mean tenting area was 2.1  0.82
cm2 (range, 1.3-4 cm2). The mean size of the implanted Carpentier
ring was 29.7  2.6. Associated procedures included the edge-to-
edge procedure (12 patients), coronary revascularization (10 pa-
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tients), and left ventricular remodeling (4 patients). There were no
hospital deaths or complications related to the modified-shape
prosthesis implantation. On predischarge echocardiography, the
mean mitral regurgitation (MR) grade was 0.5  0.65 (decreased
from a preoperative value of 3.8  0.6; P  .001), 13 patients had
no or trace MR, and 1 had mild (2) residual MR. The planimetric
mitral valve area was 2.8  0.49 cm2. No significant gradient
across the mitral valve was detected. During follow-up (5  2.5
months; range, 1-11 months), there have been no deaths or rehos-
pitalizations. The mean New York Heart Association functional
class decreased from the preoperative value of 2.6  0.6 to 1.1 
0.3 (P  .0001; 12 patients were in class I and 2 in class II).
Nonsignificant progress in mean MR severity was observed during
follow-up (from 0.5  0.65 cm2 to 0.78  0.67 cm2, P  .4). On
3-dimensional echocardiography, the annuloplasty prosthesis re-
tained the modified shape with the 2:1 ratio between the intercom-
missural and the septolateral dimensions (Figure 2).
Discussion
Undersized annuloplasty, introduced by Bolling and associ-
ates,1 is extensively used to treat FMR. The rationale is to force
leaflet coaptation by reducing annular dimensions. The ideal
undersized annuloplasty should primarily address the septolat-
eral diameter without affecting the transverse diameter so as not
to distort the anterior annulus, which is not dilated among these
patients and provides adequate mitral valve area. The available
ring prostheses were originally designed to correct degenerative
or rheumatic disease and to reduce both the transverse and the
septolateral diameters proportionally in the 4:3 ratio. Implant-
ing a size 28 ring in a size 32 mitral valve reduces the inter-
commissural diameter by 12% and the septolateral diameter by
only 25%, whereas when the shape of a Carpentier ring is
modified, as has been documented by 3-dimensional echocar-
diography, the intercommissural length is not affected, and the
septolateral diameter is reduced up to 50%. The satisfactory
mitral valve area of 2.8  0.49 cm2 found in our patients can be
explained by a single dimension reduction.
We conclude that shape modification of a ring annuloplasty
is an effective adjunct for valve repair in FMR. It provides
effective apposition of the mitral leaflets without compromising
transmitral flow and the shape of the anterior leaflet. The good
immediate and early results encourage the extension of the
indications for annuloplasty to subgroups with a high risk for
recurrence, such as patients with a coaptation depth more than
1 cm and those with complex regurgitant jets. Dedicated pro-
spective comparative studies with longer follow-up are needed
to clarify the possible advantages of this technique over con-
ventional undersized annuloplasty.
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Figure 1. a, The original Carpentier Classic ring is shown. The
prosthesis is first bent laterally by applying force on the points
depicted by the x and by having the middle of the posterior
portion of the prosthesis as the hinge. b, The initial result is a
prosthesis with a wider intercommissural dimension. c, A second
step is needed to restore the D shape of the prosthesis by bending
the prosthesis at the level of the commissures (x). d, The final
result is a prosthesis with a normalized intercommissural dis-
tance, a doubly undersized septolateral dimension, and a wider
gap in the anterior portion of the annuloplasty device (a suture is
passed across the gap to avoid future distension).
Figure 2. A follow-up 3-dimensional echocardiographic picture
showing the typical D shape of the annuloplasty prosthesis, with
a decreased septolateral dimension and with an approximately
2:1 ratio of the intercommissural-septolateral dimensions.
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